Nuvation Bio Inc. — Director's Dealing 2025

Aug 13, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvation Bio Inc. (NUVB)
CIK: 0001811063
Period of Report: 2025-08-11

Reporting Person: Mashal Robert (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-11	Stock Option (Right to Buy)	$1.55	G	350001	Disposed	2034-01-07	Class A Common Stock (350001)	Direct
2025-08-11	Stock Option (Right to buy)	$1.55	G	350001	Acquired	2034-01-07	Class A Common Stock (350001)	Indirect

Footnotes

F1: The shares underlying the option are fully vested.

F2: The reported transaction involves the reporting person's transfer of option to his irrevocable trust.